AI Article Synopsis

  • Hematopoietic stem cell transplantation (HSCT) is an effective treatment for blood-related diseases like lymphoma and multiple myeloma, and was integrated into Chile's National Cancer Program in 2004, transitioning from private to public services by 2008.* -
  • The study reports on the first ten HSCT procedures performed at the new national center, which adhered to evidence-based protocols and received approval from a national commission.* -
  • Among the ten patients treated, a majority experienced mild side effects but showed positive outcomes, with successful neutrophil and platelet recovery by days 10 and 11, respectively, leading to a conclusion that the center can serve as a model for public care, education, and research

Article Abstract

Background: Hematopoietic stem cell transplantation (HSCT) is an effective therapy for hematological diseases such as lymphoma and multiple myeloma. In 2004, the Cancer Unit of the Ministry of Health incorporated the HSCT to the National Cancer Program in Adults. Until 2008 we purchased services to private institutions while implementing the national center for HSCT of adults in the Hospital del Salvador.

Aim: To report the first ten HSCT conducted in this center.

Material And Methods: All cases were approved by a national commission for adult HSCT. The entire process was carried out based on evidence-based protocols.

Results: Six patients with Hodgkin lymphoma, three with multiple myeloma and one with a diffuse large B cell lymphoma were transplanted. Age range was 19 to 48 years and five patients were male. An average of 2.2 aphereses per patient was required. The CD 34 stem cell collection was 5.06 x 10(6) x Kg. The conditioning regimes were BEAM (carmustine, etoposide, cytosine arabinoside, melphalan) and melphalan 200 according to the underlying disease. Seventy percent of the patients developed mild to moderate mucositis and 50% had febrile neutropenia, with good response to treatment. In two cases there was an association with influenza. The engraftment of neutrophils and platelets was achieved on day +10 and +11 respectively. At follow-up until day +100, there was no morbidity or mortality.

Conclusions: These results confirm the quality standard that this intervention has achieved in our institution. The Chilean National Center for HSCT on Adults should be established as a public core care, teaching and research facility.

Download full-text PDF

Source
http://dx.doi.org/10.4067/S0034-98872012000900016DOI Listing

Publication Analysis

Top Keywords

stem cell
12
hematopoietic stem
8
multiple myeloma
8
national center
8
center hsct
8
hsct adults
8
hsct
6
[first ten
4
ten hematopoietic
4
cell
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!